Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model
Objectives: Chitosan is a green (natural, abundant, biodegradable, biocompatible) biopolymer that can be formulated to encapsulate a variety of therapeutic compounds. This study aimed to investigate chitosan nanoparticles (NPs) as a means of improving delivery of the clinically used anti-cancer agen...
| Main Authors: | , , |
|---|---|
| Format: | Journal Article |
| Published: |
John Wiley & Sons Ltd.
2013
|
| Online Access: | http://hdl.handle.net/20.500.11937/49673 |
Similar Items
Doxorubicin action on mitochondria: relevance to osteosarcoma therapy?
by: Armstrong, J., et al.
Published: (2015)
by: Armstrong, J., et al.
Published: (2015)
Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: Comparison with osteosarcoma cells
by: Tacar, O., et al.
Published: (2015)
by: Tacar, O., et al.
Published: (2015)
A nanoparticulate system that enhances the efficacy of the tumoricide Dz13 when administered proximal to the lesion site
by: Tan, M., et al.
Published: (2010)
by: Tan, M., et al.
Published: (2010)
Dz13: c-Jun Downregulation and Tumour Cell Death
by: Elahy, M., et al.
Published: (2011)
by: Elahy, M., et al.
Published: (2011)
Dz13, a c-jun DNAzyme, Is a Potent Inducer of Caspase-2 Activation
by: Dass, Crispin, et al.
Published: (2010)
by: Dass, Crispin, et al.
Published: (2010)
Direct anti-metastatic efficacy by the DNA enzyme Dz13 and downregulated MMP-2, MMP-9 and MT1-MMP in tumours
by: Tan, M., et al.
Published: (2010)
by: Tan, M., et al.
Published: (2010)
In vitro delivery and controlled release of doxorubicin for targeting osteosarcoma bone cancer
by: Kamba, Shafiu Abdullahi, et al.
Published: (2013)
by: Kamba, Shafiu Abdullahi, et al.
Published: (2013)
Doxorubicin: The dogma and the bone
by: Wong, J., et al.
Published: (2016)
by: Wong, J., et al.
Published: (2016)
Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis
by: Friedhuber, A., et al.
Published: (2015)
by: Friedhuber, A., et al.
Published: (2015)
Anti-Tumour Effect of a Chitosan Delivery System for Doxorubicin
by: Tan, M., et al.
Published: (2010)
by: Tan, M., et al.
Published: (2010)
Making gene therapy for osteosarcoma a reality
by: Broadhead, M., et al.
Published: (2010)
by: Broadhead, M., et al.
Published: (2010)
Cell and Molecular Biology Underpinning the Effects of PEDF on Cancers in General and Osteosarcoma in Particular
by: Chandolu, V., et al.
Published: (2012)
by: Chandolu, V., et al.
Published: (2012)
The Molecular Pathogenesis of Osteosarcoma: A Review
by: Choong, P., et al.
Published: (2011)
by: Choong, P., et al.
Published: (2011)
Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model
by: Broadhead, M., et al.
Published: (2011)
by: Broadhead, M., et al.
Published: (2011)
Doxorubicin, mesenchymal stem cell toxicity and antitumour activity: implications for clinical use
by: Baxter-Holland, M., et al.
Published: (2018)
by: Baxter-Holland, M., et al.
Published: (2018)
Stability of freeze-dried pH-responsive dextrin nanogels containing doxorubicin
by: Manchun, S., et al.
Published: (2016)
by: Manchun, S., et al.
Published: (2016)
Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?
by: Tacar, O., et al.
Published: (2013)
by: Tacar, O., et al.
Published: (2013)
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
by: Tacar, O., et al.
Published: (2013)
by: Tacar, O., et al.
Published: (2013)
Efficacy of Continuously Administered PEDF-Derived Synthetic Peptides against Osteosarcoma Growth and Metastasis
by: Broadhead, M., et al.
Published: (2012)
by: Broadhead, M., et al.
Published: (2012)
Thiolated pectin–doxorubicin conjugates: Synthesis, characterization and anticancer activity studies
by: Cheewatanakornkool, K., et al.
Published: (2017)
by: Cheewatanakornkool, K., et al.
Published: (2017)
RANK-Fc inhibits malignancy via inhibiting ERK activation and evoking caspase-3-mediated anoikis in human osteosarcoma cells
by: Akiyama, T., et al.
Published: (2010)
by: Akiyama, T., et al.
Published: (2010)
The Effect of Krill Oil and n-3 Polyunsaturated Fatty Acids on Human Osteosarcoma Cell Proliferation and Migration.
by: Xiao, S., et al.
Published: (2015)
by: Xiao, S., et al.
Published: (2015)
Enhanced anti-tumor effect of pH-responsive dextrin nanogels delivering doxorubicin on colorectal cancer
by: Manchun, S., et al.
Published: (2015)
by: Manchun, S., et al.
Published: (2015)
Canine osteosarcoma: a relevant comparative model for osteosarcoma in man
by: Selvarajah, Gayathri Thevi
Published: (2011)
by: Selvarajah, Gayathri Thevi
Published: (2011)
Redox-responsive microbeads containing thiolated pectin-doxorubicin conjugate inhibit tumor growth and metastasis: An in vitro and in vivo study
by: Cheewatanakornkool, K., et al.
Published: (2018)
by: Cheewatanakornkool, K., et al.
Published: (2018)
Novel pH-responsive dextrin nanogels for doxorubicin delivery to cancer cells with reduced cytotoxicity to cardiomyocytes and stem cells
by: Manchun, S., et al.
Published: (2014)
by: Manchun, S., et al.
Published: (2014)
Zoledronic acid: Pleiotropic anti-tumor mechanism and therapeutic outlook for osteosarcoma
by: Ouyang, Z., et al.
Published: (2018)
by: Ouyang, Z., et al.
Published: (2018)
Characterization and in vitro release studies of oral microbeads containing thiolated pectin-doxorubicin conjugates for colorectal cancer treatment
by: Cheewatanakornkool, K., et al.
Published: (2017)
by: Cheewatanakornkool, K., et al.
Published: (2017)
Enhanced anti-inflammatory effects of nanoencapsulated diclofenac
by: Goh, Jun Zheng, et al.
Published: (2013)
by: Goh, Jun Zheng, et al.
Published: (2013)
RECK in Osteosarcoma: A Novel Role in Tumour Vasculature and Inhibition of Tumorigenesis in an Orthotopic Mode
by: Clark, J., et al.
Published: (2011)
by: Clark, J., et al.
Published: (2011)
Eupatorin suppressed tumour progression and enhanced immunity in a 4T1 murine breast cancer model
by: Abd Razak, Nursyamirah, et al.
Published: (2020)
by: Abd Razak, Nursyamirah, et al.
Published: (2020)
Levodopa nanoencapsulation in nanostarch as anti-parkinsonian drugs candidate
by: Sardjono, Ratnaningsih Eko, et al.
Published: (2023)
by: Sardjono, Ratnaningsih Eko, et al.
Published: (2023)
Nanoencapsulated aroma finishing on fabric by sol-gel process
by: W. N. W., Ismail
Published: (2021)
by: W. N. W., Ismail
Published: (2021)
Role of vitamin D metabolism in cutaneous tumour formation and progression
by: Nemazannikova, N., et al.
Published: (2013)
by: Nemazannikova, N., et al.
Published: (2013)
Pigment epithelium-derived factor upregulates collagen I and downregulates matrix metalloproteinase 2 in osteosarcoma cells, and colocalises to collagen I and heat shock protein 47 in fetal and adult bone
by: Alcantara, M., et al.
Published: (2014)
by: Alcantara, M., et al.
Published: (2014)
Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 diabetes
by: Mooranian, Armin, et al.
Published: (2018)
by: Mooranian, Armin, et al.
Published: (2018)
Protocatechuic acid induces apoptosis in human osteosarcoma cells by regulating P13K/AKT/ROS pathway
by: Mei, Qiyuan, et al.
Published: (2022)
by: Mei, Qiyuan, et al.
Published: (2022)
Chemical Composition And Nanoencapsulation Of Cynometra Cauliflora Essential Oils And Their Biological Activity Studies
by: Samling, Benedict
Published: (2023)
by: Samling, Benedict
Published: (2023)
Nanoencapsulation Of Thiolated Sodium Alginate: Synthesis, Drug Release And Cellular Uptake Studies
by: Chiu, Hocking
Published: (2018)
by: Chiu, Hocking
Published: (2018)
Development of cockleshell (Anadara granosa) derived CaCO3 nanoparticle for doxorubicin delivery
by: Danmaigoro, Abubakar, et al.
Published: (2017)
by: Danmaigoro, Abubakar, et al.
Published: (2017)